Theriva Biologics, Inc.
USD0.25
-0.01 (-3.77%)
CEO
Steven A. Shallcross
IPO Date
2006-12-18
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$0.25
Prev. Close
$0.26
Day Low
$0.25
Day High
$0.26
52W Low
$0.16
52W High
$0.86
Market Cap
$0.01B
Volume
0.45M
| -0.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -46.2% | -33.2% | 0.05 | 4.07 | -0.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -36.1% | -27.4% | 0.03 | 6.45 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -21.8% | -20.3% | 0.02 | 19.37 | -58.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -125.1% | -119.4% | 0.06 | 2.67 | -18.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -106.5% | -88.8% | 0.05 | 3.11 | -13.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -45.5% | -44.3% | 0.00 | 8.72 | -6.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 1014.3% | -80.5% | 0.00 | 1.83 | -107.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -708.8% | -121.1% | 0.00 | 1.09 | -65.9 |
| -0.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -64.7% | -14.1% | 0.41 | 0.90 | -0.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -122.9% | -36.4% | 0.27 | 1.19 | -0.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -27.9% | -13.4% | 0.18 | 1.53 | -0.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -23.3% | -12.6% | 0.08 | 2.15 | -0.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -31.4% | -19.3% | 0.07 | 2.67 | -0.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -30.1% | -19.6% | 0.07 | 2.88 | -0.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.1% | -10.6% | 0.06 | 3.60 | -0.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -13.8% | -9.9% | 0.05 | 4.07 | -0.3 |